1. Home
  2. SXT vs CPRX Comparison

SXT vs CPRX Comparison

Compare SXT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • CPRX
  • Stock Information
  • Founded
  • SXT 1882
  • CPRX 2002
  • Country
  • SXT United States
  • CPRX United States
  • Employees
  • SXT N/A
  • CPRX N/A
  • Industry
  • SXT Major Chemicals
  • CPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SXT Industrials
  • CPRX Health Care
  • Exchange
  • SXT Nasdaq
  • CPRX Nasdaq
  • Market Cap
  • SXT 3.4B
  • CPRX 2.8B
  • IPO Year
  • SXT N/A
  • CPRX 2006
  • Fundamental
  • Price
  • SXT $76.96
  • CPRX $20.60
  • Analyst Decision
  • SXT Buy
  • CPRX Strong Buy
  • Analyst Count
  • SXT 1
  • CPRX 6
  • Target Price
  • SXT $85.00
  • CPRX $30.50
  • AVG Volume (30 Days)
  • SXT 151.7K
  • CPRX 1.0M
  • Earning Date
  • SXT 10-25-2024
  • CPRX 11-06-2024
  • Dividend Yield
  • SXT 2.13%
  • CPRX N/A
  • EPS Growth
  • SXT N/A
  • CPRX 114.68
  • EPS
  • SXT 2.09
  • CPRX 1.18
  • Revenue
  • SXT $1,530,110,000.00
  • CPRX $460,482,000.00
  • Revenue This Year
  • SXT $8.14
  • CPRX $21.99
  • Revenue Next Year
  • SXT $4.13
  • CPRX $17.95
  • P/E Ratio
  • SXT $36.80
  • CPRX $17.48
  • Revenue Growth
  • SXT 5.10
  • CPRX 32.17
  • 52 Week Low
  • SXT $55.02
  • CPRX $13.00
  • 52 Week High
  • SXT $82.99
  • CPRX $24.27
  • Technical
  • Relative Strength Index (RSI)
  • SXT 46.18
  • CPRX 39.71
  • Support Level
  • SXT $77.55
  • CPRX $21.30
  • Resistance Level
  • SXT $80.74
  • CPRX $24.27
  • Average True Range (ATR)
  • SXT 1.74
  • CPRX 0.79
  • MACD
  • SXT -0.07
  • CPRX -0.18
  • Stochastic Oscillator
  • SXT 33.94
  • CPRX 4.18

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Share on Social Networks: